ArticleFrontiers in pharmacology2021

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy.

Lei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.